Literature DB >> 12584744

In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure.

Pasquina Marzola1, Paolo Farace, Laura Calderan, Caterina Crescimanno, Ernesto Lunati, Elena Nicolato, Donatella Benati, Anna Degrassi, Andrea Terron, Jan Klapwijk, Enrico Pesenti, Andrea Sbarbati, Francesco Osculati.   

Abstract

Contrast-enhanced MRI, immunostaining and electron microscopy were used to detect areas of intense angiogenesis in experimental tumors. This work was also aimed at evaluating the possible effect of the surrounding tissues on tumor microvasculature and at studying the penetration of macromolecules in avascular areas. Human colon carcinoma cells were implanted in subcutaneous tissue of nude mice. Dynamic T(1)-weigthed 3D pulse sequences were acquired before and after administration of Gd-DTPA-albumin to obtain parametric maps of fractional plasma volume (fpv) and transendothelial permeability (Kps). The maps suggested that tumor can be subdivided into 4 zones located in the peripheral rim (zones I-II) or in the core (zones III-IV) of the tumor itself. Significant differences (p<0.001) were found in the values of Kps and fpv of zones I-II with respect to zones III-IV. In the peripheral rim, permeability was significantly higher (p<0.01) in the muscle-peripheral region (zone I) with respect to the skin-peripheral region (zone II). In areas with high Kps, histological and ultrastructural examination revealed clusters of newly formed vessels and signs of intense permeability. Numerous vascular vesicular organs were visible in these areas. In the tumoral core, analysis of the microcirculatory parameters revealed regions with mild permeability (zone III) and regions with negligible permeability (zone IV). These 2 zones were discriminated by the average value of Kps (p<0.05), while their fpv was not significantly different. Upon histological examination, the tumoral core exhibited necrotic areas; CD31 immunocytochemistry exhibited that it was diffusely hypovascularized with large avascular areas. Upon ultrastructural examination, capillaries were rarely visible and exhibited signs of endothelial cell damage. The results suggest that segmentation based on microvascular parameters detects in vivo zones characterized by immunocytochemical and ultrastructural aspects of intense angiogenesis. The finding that a certain amount of contrast agent penetrates in the tumoral core suggests that high oncotic and hydrostatic pressure only partially hinders the penetration of macromolecules. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584744     DOI: 10.1002/ijc.10953

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors.

Authors:  Meng Law; Khuram Kazmi; Stephan Wetzel; Edwin Wang; Codrin Iacob; David Zagzag; John G Golfinos; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

2.  Tumor vessel compression hinders perfusion of ultrasonographic contrast agents.

Authors:  Mirco Galiè; Mirko D'Onofrio; Maura Montani; Augusto Amici; Laura Calderan; Pasquina Marzola; Donatella Benati; Flavia Merigo; Cristina Marchini; Andrea Sbarbati
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

3.  Dynamic contrast-enhanced MR microscopy identifies regions of therapeutic response in a preclinical model of colorectal adenocarcinoma.

Authors:  Ergys Subashi; Yi Qi; G Allan Johnson
Journal:  Med Phys       Date:  2015-05       Impact factor: 4.071

4.  PWI-MRI and contrast extravasation in brain AVM help to estimate angiogenic activity.

Authors:  Guillaume Saliou; Timo Krings; Dik R Rutgers; Frederique Toulgoat; Augustin Ozanne; Pierre Lasjaunias; Denis Ducreux
Journal:  Neuroradiology       Date:  2011-05-12       Impact factor: 2.804

5.  Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI.

Authors:  Chunhao Wang; Ergys Subashi; Fang-Fang Yin; Zheng Chang
Journal:  Med Phys       Date:  2016-03       Impact factor: 4.071

6.  The role of heparanase in lymph node metastatic dissemination: dynamic contrast-enhanced MRI of Eb lymphoma in mice.

Authors:  Hagit Dafni; Batya Cohen; Keren Ziv; Tomer Israely; Orit Goldshmidt; Nava Nevo; Alon Harmelin; Israel Vlodavsky; Michal Neeman
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

7.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

Authors:  Meng Law; Stanley Yang; James S Babb; Edmond A Knopp; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

8.  Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.

Authors:  Mirco Galiè; Paolo Farace; Cristina Nanni; Antonello Spinelli; Elena Nicolato; Federico Boschi; Paolo Magnani; Silvia Trespidi; Valentina Ambrosini; Stefano Fanti; Flavia Merigo; Francesco Osculati; Pasquina Marzola; Andrea Sbarbati
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

9.  A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas.

Authors:  H S Kim; S Y Kim
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

10.  Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma.

Authors:  Meser M Ali; Branislava Janic; Abbas Babajani-Feremi; Nadimpalli R S Varma; A S M Iskander; John Anagli; Ali S Arbab
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.